JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VIP
5951
Vulcan Infrastructure and Power
VIP
$27.8M
| $6K | ﹤0.01% |
1,239
+482
| +64% | +$2.92K |
2021 Q3
6 quarters
|
|
5952
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$72.5M
| $6K | ﹤0.01% |
204
+85
| +71% | +$2.63K |
2022 Q1
4 quarters
|
|
5953
MidCap Financial Investment
MFIC
$703M
| $6K | ﹤0.01% |
505
-2,201
| -81% | -$26.4K |
2013 Q2
39 quarters
|
|
5954
OP Bancorp
OPBK
$229M
| $6K | ﹤0.01% |
643
+556
| +639% | +$6K |
2018 Q2
19 quarters
|
|
5955
Oric Pharmaceuticals
ORIC
$1.29B
| $6K | ﹤0.01% |
1,160
+400
| +53% | +$2.09K |
2020 Q2
11 quarters
|
|
5956
RPAR Risk Parity ETF
RPAR
$545M
| $6K | ﹤0.01% |
293
| – | – |
2022 Q1
4 quarters
|
|
5957
ProShares Short Russell2000
RWM
$152M
| $6K | ﹤0.01% |
+246
| New | +$5.76K |
2023 Q1
0 quarters
|
|
5958
Stabilis Solutions
SLNG
$94.5M
| $6K | ﹤0.01% |
1,727
| – | – |
2022 Q4
1 quarter
|
|
5959
CALL
Synchrony
SYF
$23.3B
| $6K | ﹤0.01% |
+200
| New | +$6.72K |
2023 Q1
0 quarters
|
|
5960
CALL
TotalEnergies
TTE
$188B
| $6K | ﹤0.01% |
+100
| New | +$6.15K |
2023 Q1
0 quarters
|
|
5961
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$11.1M
| $6K | ﹤0.01% |
500
-130
| -21% | -$1.65K |
2021 Q2
7 quarters
|
|
5962
Invesco Pennsylvania Value Municipal Income Trust
VPV
$191M
| $6K | ﹤0.01% |
+643
| New | +$6.49K |
2023 Q1
0 quarters
|
|
|
PSTX
5963
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $6K | ﹤0.01% |
1,749
-29,475
| -94% | -$177K |
2020 Q3
10 quarters
|
|
|
PRLHW
5964
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
| – | – |
0
| – | – |
2022 Q2
3 quarters
|
|
|
CTG
5965
DELISTED
Computer Task Group, Inc.
CTG
| $6K | ﹤0.01% |
+825
| New | +$6.1K |
2023 Q1
0 quarters
|
|
|
HYLD
5966
DELISTED
High Yield ETF
HYLD
| $6K | ﹤0.01% |
+238
| New | +$6.36K |
2023 Q1
0 quarters
|
|
|
BIOR
5967
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $6K | ﹤0.01% |
+224
| New | +$7.59K |
2023 Q1
0 quarters
|
|
|
CHW
5968
Calamos Global Dynamic Income Fund
CHW
$512M
| $5.84K | ﹤0.01% |
977
-3,367
| -78% | -$20.4K |
2022 Q3
2 quarters
|
|
5969
T. Rowe Price Equity Income ETF
TEQI
$473M
| $5.52K | ﹤0.01% |
165
+164
| +16,400% | +$5.66K |
2022 Q4
1 quarter
|
|
5970
US Vegan Climate ETF
VEGN
$191M
| $5.35K | ﹤0.01% |
165
+155
| +1,550% | +$5.25K |
2022 Q4
1 quarter
|
|
5971
iShares Global Financials ETF
IXG
$693M
| $5.14K | ﹤0.01% |
74
-36
| -33% | -$2.63K |
2018 Q4
17 quarters
|
|
|
ABX
5972
Abacus Global Management
ABX
$805M
| $5K | ﹤0.01% |
448
| – | – |
2022 Q2
3 quarters
|
|
5973
Acumen Pharmaceuticals
ABOS
$150M
| $5K | ﹤0.01% |
1,237
+108
| +10% | +$564 |
2021 Q3
6 quarters
|
|
5974
a.k.a. Brands
AKA
$120M
| $5K | ﹤0.01% |
714
+75
| +12% | +$1.14K |
2021 Q4
5 quarters
|
|
5975
Backblaze
BLZE
$869M
| $5K | ﹤0.01% |
+1,087
| New | +$6.59K |
2023 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.